Schonfeld Strategic Advisors’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,210
| Closed | -$7.99K | – | 2372 |
|
|
2024
Q2 | $7.99K | Sell |
1,210
-1,710
| -59% | -$11.3K | ﹤0.01% | 1879 |
|
|
2024
Q1 | $32.1K | Sell |
2,920
-950
| -25% | -$10.5K | ﹤0.01% | 1722 |
|
|
2023
Q4 | $52.2K | Sell |
3,870
-240
| -6% | -$3.24K | ﹤0.01% | 1577 |
|
|
2023
Q3 | $89.2K | Buy |
4,110
+30
| +0.7% | +$651 | ﹤0.01% | 1365 |
|
|
2023
Q2 | $157K | Sell |
4,080
-170
| -4% | -$6.55K | ﹤0.01% | 1556 |
|
|
2023
Q1 | $118K | Buy |
+4,250
| New | +$118K | ﹤0.01% | 1616 |
|
|
2021
Q4 | – | Sell |
-52
| Closed | -$20K | – | 2579 |
|
|
2021
Q3 | $20K | Buy |
+52
| New | +$20K | ﹤0.01% | 1943 |
|
|
2021
Q1 | – | Sell |
-113
| Closed | -$150K | – | 2170 |
|
|
2020
Q4 | $150K | Sell |
113
-444
| -80% | -$589K | ﹤0.01% | 1357 |
|
|
2020
Q3 | $1.26M | Sell |
557
-193
| -26% | -$435K | 0.02% | 611 |
|
|
2020
Q2 | $1.69M | Buy |
+750
| New | +$1.69M | 0.04% | 419 |
|